In today’s recent session, 0.65 million shares of the Beam Therapeutics Inc (NASDAQ:BEAM) have been traded, and its beta is 2.21. Most recently the company’s share price was $18.26, and it changed around -$1.56 or -7.87% from the last close, which brings the market valuation of the company to $1.84B. BEAM at last check was trading at a discount to its 52-week high of $35.25, offering almost -93.04% off that amount. The share price’s 52-week low was $13.52, which indicates that the recent value has risen by an impressive 25.96% since then.
Beam Therapeutics Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.39. If we narrow it down even further, the data shows that 0 out of 16 analysts rate the stock as a Sell; another 4 rate it as Overweight. Among the rest, 2 recommended BEAM as a Hold, whereas 10 deemed it a Buy, and 0 rated it as Underweight.
Beam Therapeutics Inc (NASDAQ:BEAM) trade information
Instantly BEAM has been showing red trend so far today with a performance of -7.87% on intraday trading today. The performance over the last five days has remained in the red territory. The rise to weekly highs of 20.90 on recent trading dayincreased the stock’s daily price by 12.63%. The company’s shares are currently down -26.37% year-to-date, but still down -7.36% over the last five days. On the other hand, Beam Therapeutics Inc (NASDAQ:BEAM) is 19.58% up in the 30-day period.
The consensus price target as assigned by Wall Street analysts is $31, which translates to bulls needing to increase their stock price by 41.1% from its current value. Analyst projections state that BEAM is forecast to be at a low of $25 and a high of $37.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -20.88%. Beam Therapeutics Inc earnings are expected to increase by -3.23% in 2025, but the outlook is negative -1.10% per year for the next five years.
BEAM Dividends
Beam Therapeutics Inc’s next quarterly earnings report is expected to be released in June.
VANGUARD GROUP INC, with 9.598% or 7.9 million shares worth $185.11 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
ARK ETF Trust-ARK Innovation ETF and iShares Trust-iShares Russell 2000 ETF were the top two Mutual Funds as of Mar 31, 2025 . The former held 5.75 shares worth $106.12 million, making up 5.72% of all outstanding shares. On the other hand, iShares Trust-iShares Russell 2000 ETF held roughly 2.4 shares worth around $44.35 million, which represents about 2.39% of the total shares outstanding.
